Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Net Cash Flow: 2016-2024

Historic Net Cash Flow for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to $23.0 million.

  • Arcus Biosciences' Net Cash Flow fell 122.22% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 117.65%. This contributed to the annual value of $23.0 million for FY2024, which is 129.11% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Net Cash Flow is $23.0 million, which was up 129.11% from -$79.0 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Net Cash Flow ranged from a high of $116.0 million in FY2020 and a low of -$79.0 million during FY2023.
  • Moreover, its 3-year median value for Net Cash Flow was $23.0 million (2024), whereas its average is $666,667.
  • Per our database at Business Quant, Arcus Biosciences' Net Cash Flow skyrocketed by 983.67% in 2020 and then slumped by 236.21% in 2023.
  • Yearly analysis of 5 years shows Arcus Biosciences' Net Cash Flow stood at $116.0 million in 2020, then slumped by 119.83% to -$23.0 million in 2021, then skyrocketed by 352.17% to $58.0 million in 2022, then tumbled by 236.21% to -$79.0 million in 2023, then spiked by 129.11% to $23.0 million in 2024.